December 23, 2019
On December 24th, Shimadzu Corporation simultaneously released six new UV-VIS spectrophotometer models under a new UV-i Selection brand. UV-i Selection brand models are equipped standard with LabSolutions UV-Vis analytical data system for UV-VIS spectrophotometers (released April 2018). By including highly user-friendly operability, the ability to automatically analyze multiple samples continuously, and other features for satisfying [...]
SGI-DNA Appoints Brian Donnelly as Chief Commercial Officer
December 23, 2019
SAN DIEGO, California SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DBA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer. Mr. Donnelly is a seasoned commercial and operational leader with expertise in developing markets and launching disruptive technologies in [...]
December 23, 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the International Trade Commission (ITC) affirmed the Administrative Law Judge’s finding that 10X Genomics infringed three of Bio-Rad’s patents. The Commission also issued a Limited Exclusion Order and Cease and Desist Order against 10X [...]
Alliance Global signs exclusive distribution agreement with Euformatics
December 20, 2019
DUBAI, UAE, December, 2019 – Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has appointed Dubai-headquartered Alliance Global (AGBL) as the exclusive distributor for its bioinformatics software in the Middle East, Asia and Africa. “Euformatics is delighted to be working with Alliance Global as our exclusive distributor in the region to [...]
December 20, 2019
LAUSANNE, Switzerland – Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closing of a CHF 1.8 million Seed financing round. Investors in the round include the leading Swiss venture capital platform investiere, Zürcher Kantonalbank, NEST pension fund and private investors from [...]
Akadeum Life Sciences Announces First Closing of Series A Financing Round
December 19, 2019
ANN ARBOR, Mich. -- Akadeum Life Sciences, Inc. announced an initial close of its Series A financing. The company is pursuing additional investment before final close during Q1 2020. These funds will enable Akadeum to focus its commercial adoption on how to solve longstanding problems in sample preparation. The investment includes several Michigan-based angel groups in addition [...]
Mayo Clinic Adopts Bionano Saphyr For Applications in Neurodegenerative Diseases
December 19, 2019
Saphyr helps provide a better understanding of ALS, Alzheimer’s disease and Parkinson’s disease SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Mayo Clinic has adopted the Saphyr system. A team led by Dr. Mark Ebbert brought the Saphyr system in-house after determining that Bionano’s technology can provide a deeper understanding of the [...]
December 19, 2019
The Sartorius AI Lab (SAIL) conducts research in the use of artificial intelligence in Sartorius platform solutions for the biopharmaceutical industry KAISERSLAUTERN and GÖTTINGEN, Germany, - Sartorius, a leading international partner of life science research and the biopharmaceutical industry, and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius AI Lab (SAIL) [...]
December 19, 2019
Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V.. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for biopharmaceutical production and research, with an annual net sales of approximately SEK 450 M. “Applikon Biotechnology has a [...]
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
December 19, 2019
Gives scientists a new view into natural cell activity, accelerating drug development MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, access to MilliporeSigma’s foundational CRISPR intellectual property. Promega will use MilliporeSigma’s CRISPR genome-editing technology to create research products [...]

